Menu
Sign In Search Podcasts Charts Entities Add Podcast API Pricing
Podcast Image

The Matt Walsh Show

Ep. 1317 - Major Medical Organization Gives Male 'Breastfeeding' Its Stamp Of Approval

21 Feb 2024

Description

Today on the Matt Walsh Show, a major medical organization has come out in support of male "breastfeeding." If you thought that major medical organizations had already lost all the credibility they possibly could, think again. Also, Dr. Phil and Joe Rogan discuss the dangers of "gender affirming care." A new study shows that the COVID vax was not as safe as they told us. And this is just the tip of the iceberg. And Beyonce has a new country song out. My take on the song might surprise you.   Ep.1317   - - -    DailyWire+:   Get 20% off SITEWIDE during our Presidents Day Sale! Shop here: https://bit.ly/3I7WaAr   Unlock your Bentkey 14-day free trial here: https://bit.ly/3GSz8go   Shop my merch collection here: https://bit.ly/3EbNwyj    - - -    Today's Sponsors:    Birch Gold - Text "WALSH" to 989898, or go to https://birchgold.com/Walsh, for your no-cost, no-obligation, FREE information kit.   PureTalk - Get a FREE Samsung 5G smartphone. Enter promo code: Walsh at   https://bit.ly/3Mk5JiE   PreBorn! - Help save babies from abortion: https://preborn.com/Matt    Policygenius - Get your free life insurance quote & see how much you could save: http://policygenius.com/Walsh    Tax Network USA - Seize control of your financial future! Call 1(800)245-6000 or visit http://www.TNUSA.com/Walsh    - - -   Socials:   Follow on Twitter: https://bit.ly/3Rv1VeF   Follow on Instagram: https://bit.ly/3KZC3oA   Follow on Facebook: https://bit.ly/3eBKjiA   Subscribe on YouTube: https://bit.ly/3RQp4rs Learn more about your ad choices. Visit megaphone.fm/adchoices

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.